PD-1/PD-L1 inhibitors as neoadjuvant therapies in resectable non-small cell lung cancer, including their effects in various PD-1 expression subtypes: A meta-analysis.
Authors: Mohamed E. Ali, Mohammed S Beshr, Rana H. Shembesh, Muhammed Elhadi, Atif Hussein